Diatheva

Founded in 2002 in Cartoceto (PU), Italy, Diatheva is a biotechnology company established as a spin-off from the University of Urbino. 70% of all employees holds at least a PhD and oversees all phases of activity, from research and development to production and finishing. For 20 years, Diatheva has been engaged in the research, development, and production of: - biotechnological products: including monoclonal and polyclonal antibodies, antibody fragments, recombinant proteins, recombinant enzymes, and antigens - molecular and immunoenzymatic assays: such as in vitro diagnostics (IVD), veterinary kits, food analysis kits, and environmental kits. To achieve this, Diatheva collaborates with companies, public and private entities, mainly operating in the fields of oncology, microbial infections, and pharmacogenetics. Diatheva operates a cutting-edge GMP production facility authorized by AIFA since 2006 for biomolecules (APIs) and since 2023 for medicinal products.